Clinical trial Recruiting at 3 sites Early Phase 1 Interventional Ages 18 to 80

Improving hand function after spinal cord injury using electrical stimulation

Official title: Spinal Cord Associative Plasticity Study

Run by Columbia University · NCT05163639 · Data updated 2026-11-12

This study is testing if a new way of using electrical stimulation on the brain and spinal cord can help people with cervical spinal cord injuries regain better control and movement in their arms and hands.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment92 (estimated)
SponsorColumbia University
Academic / other
Locations3 sites (New York, New York and 2 other locations)
StatusRecruiting
StartedSeptember 10, 2021
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedJune 18, 2026
Trial IDNCT05163639 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-80 with cervical spinal cord injuries who have some residual muscle function in their hands.

Probably not a fit

Patients with extensive neurological diseases or those who are ventilator-dependent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates spinal cord associative plasticity (SCAP), a technique that combines cortical and spinal electrical stimulation to enhance recovery of arm and hand function in individuals with cervical spinal cord injuries. The research aims to determine if electrical stimulation can strengthen signaling through the spinal cord to the muscles and improve understanding of spinal cord function. Participants will undergo both non-invasive and intraoperative stimulation to assess the effects of paired brain and spinal cord stimulation on muscle activation and movement recovery. The study seeks to translate promising animal research into human therapy for those with paralysis or weakness following spinal cord injury.

Why it matters

Potential benefit: If successful, this approach could lead to new therapies that significantly improve hand and arm function in patients with spinal cord injuries.

How similar studies have gone: Previous studies in animal models have shown success with similar stimulation techniques, but this approach is novel in human subjects.

Who can join: the full rules

Show full inclusion / exclusion criteria
NON-INVASIVE

Inclusion Criteria:

(All participants)

* Age between 18-80 years.
* Must have stable prescription medication for 30 days prior to screening
* Must be able to: abstain from alcohol, smoking and caffeine consumption on the day of each experiment; abstain from recreational drugs for the entirety of the study; commit to study requirements (i.e., 7 visits); provide informed consent.

(Able-bodied participants)

* No known central or peripheral neurological disease or injury.

(SCI participants - including patients scheduled for intraoperative procedures)

* Score of 1-4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction in left or right hand.

Exclusion criteria:

(All participants)

* Personal or extensive family history of seizures;
* Ventilator dependence or patent tracheostomy site;
* Use of medications that significantly lower seizure threshold, such as amphetamines, neuroleptics, dalfampridine, and bupropion;
* History of stroke, brain tumor, brain abscess, or multiple sclerosis;
* History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging);
* History of implanted brain/spine/nerve stimulators, aneurysm clips, ferromagnetic metallic implants in the head (except for inside mouth); cochlear implants; cardiac pacemaker/defibrillator; intracardiac lines; currently increased intracranial pressure; or other contraindications to brain or spine stimulation;
* Significant coronary artery or cardiac conduction disease; recent history of myocardial infarction and heart failure with an ejection fraction of less than 30% or with a New York Heart Association Functional Classification of Class III or IV;
* Recent history (within past 6 months) of recurrent autonomic dysreflexia, defined as a syndrome of sudden rise in systolic pressure greater than 20 mm Hg or diastolic pressure greater than 10 mm Hg, without rise in heart rate, accompanied by symptoms such as headache, facial flushing, sweating, nasal congestion, and blurry vision (this will be closely monitored during all screening and testing procedures);
* History of significant hearing problems;
* History of bipolar disorder;
* History of suicide attempt;
* Active psychosis;
* Recent history (\>1 year) of chemical substance dependency or significant psychosocial disturbance;
* Heavy alcohol consumption (greater than equivalent of 5oz of liquor) within previous 48 hours;
* Open skin lesions over the face, neck, shoulders, or arms;
* Pregnancy; and
* Unsuitable for study participation as determined by study physician.

INTRA-OPERATIVE

Inclusion Criteria:

* Clinical indication for cervical spine surgery.

Exclusion criteria:

(For experiments involving cortical stimulation)

* Epilepsy;
* A history of skull surgery with metal implants;
* Cochlear implants;
* Patients with aneurysm stents in neck or brain blood vessels;
* Evidence of skull shrapnel; (For experiments involving spinal cord stimulation)
* Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)

Where it's running

  • Bronx Veterans Medical Research Foundation, Inc
    New York, New York, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Jason B Carmel, M.D., Ph.D. — Columbia University
  • Study coordinator: Jason B Carmel, M.D., Ph.D.
  • Email: jbc28@cumc.columbia.edu
  • Phone: 917-301-1882

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.